These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 15645424)
1. Use of a transgenic mouse model to identify markers of human lung tumors. Linnerth NM; Sirbovan K; Moorehead RA Int J Cancer; 2005 May; 114(6):977-82. PubMed ID: 15645424 [TBL] [Abstract][Full Text] [Related]
2. [Syndecan-1 (CD138): an immunohistochemical marker of plasma cell tumors]. Fakan F; Boudová L; Hejda C Cesk Patol; 2002 Jan; 38(1):33-6. PubMed ID: 11933459 [TBL] [Abstract][Full Text] [Related]
3. Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma. Shah L; Walter KL; Borczuk AC; Kawut SM; Sonett JR; Gorenstein LA; Ginsburg ME; Steinglass KM; Powell CA Cancer; 2004 Oct; 101(7):1632-8. PubMed ID: 15378500 [TBL] [Abstract][Full Text] [Related]
4. Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer. Joensuu H; Anttonen A; Eriksson M; Mäkitaro R; Alfthan H; Kinnula V; Leppä S Cancer Res; 2002 Sep; 62(18):5210-7. PubMed ID: 12234986 [TBL] [Abstract][Full Text] [Related]
5. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Matsuda K; Maruyama H; Guo F; Kleeff J; Itakura J; Matsumoto Y; Lander AD; Korc M Cancer Res; 2001 Jul; 61(14):5562-9. PubMed ID: 11454708 [TBL] [Abstract][Full Text] [Related]
6. Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma. Rintala M; Inki P; Klemi P; Jalkanen M; Grénman S Gynecol Oncol; 1999 Dec; 75(3):372-8. PubMed ID: 10600292 [TBL] [Abstract][Full Text] [Related]
7. Can syndecan-1 become a prognostic factor in solid tumors? Oguri K; Okayama M J Gastroenterol; 2004; 39(2):197-9. PubMed ID: 15074308 [No Abstract] [Full Text] [Related]
8. Syndecan-1 expression is upregulated in degenerating articular cartilage in a transgenic mouse model for osteoarthritis. Salminen-Mankonen H; Säämänen AM; Jalkanen M; Vuorio E; Pirilä L Scand J Rheumatol; 2005; 34(6):469-74. PubMed ID: 16393771 [TBL] [Abstract][Full Text] [Related]
9. Increased syndecan expression following myocardial infarction indicates a role in cardiac remodeling. Finsen AV; Woldbaek PR; Li J; Wu J; Lyberg T; Tønnessen T; Christensen G Physiol Genomics; 2004 Feb; 16(3):301-8. PubMed ID: 14625378 [TBL] [Abstract][Full Text] [Related]
10. High syndecan-1 expression is associated with favourable outcome in squamous cell lung carcinoma treated with radical surgery. Anttonen A; Heikkilä P; Kajanti M; Jalkanen M; Joensuu H Lung Cancer; 2001 Jun; 32(3):297-305. PubMed ID: 11390011 [TBL] [Abstract][Full Text] [Related]
11. Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis. Chen CL; Ou DL Hum Pathol; 2006 Oct; 37(10):1279-85. PubMed ID: 16949936 [TBL] [Abstract][Full Text] [Related]
12. Syndecan-1 in multiple myeloma: relationship to conventional prognostic factors. Aref S; Goda T; El-Sherbiny M Hematology; 2003 Aug; 8(4):221-8. PubMed ID: 12911939 [TBL] [Abstract][Full Text] [Related]
13. [The expression of cell adhesion molecule Syndecan-1 and E-candherin in laryngeal cancer]. Li Y; Yang C Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Dec; 17(12):736-8. PubMed ID: 15017723 [TBL] [Abstract][Full Text] [Related]
14. Correlation between reduction of syndecan-1 expression and clinico-pathological parameters in squamous cell carcinoma of tongue. Ro Y; Muramatsu T; Shima K; Yajima Y; Shibahara T; Noma H; Shimono M Int J Oral Maxillofac Surg; 2006 Mar; 35(3):252-7. PubMed ID: 16280239 [TBL] [Abstract][Full Text] [Related]
15. Scrib heterozygosity predisposes to lung cancer and cooperates with KRas hyperactivation to accelerate lung cancer progression in vivo. Elsum IA; Yates LL; Pearson HB; Phesse TJ; Long F; O'Donoghue R; Ernst M; Cullinane C; Humbert PO Oncogene; 2014 Nov; 33(48):5523-33. PubMed ID: 24276238 [TBL] [Abstract][Full Text] [Related]
16. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. Schmidt LH; Spieker T; Koschmieder S; Schäffers S; Humberg J; Jungen D; Bulk E; Hascher A; Wittmer D; Marra A; Hillejan L; Wiebe K; Berdel WE; Wiewrodt R; Muller-Tidow C J Thorac Oncol; 2011 Dec; 6(12):1984-92. PubMed ID: 22088988 [TBL] [Abstract][Full Text] [Related]
17. Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer. Acuff HB; Sinnamon M; Fingleton B; Boone B; Levy SE; Chen X; Pozzi A; Carbone DP; Schwartz DR; Moin K; Sloane BF; Matrisian LM Cancer Res; 2006 Aug; 66(16):7968-75. PubMed ID: 16912171 [TBL] [Abstract][Full Text] [Related]
19. Up regulation of cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis. Morko JP; Söderström M; Säämänen AM; Salminen HJ; Vuorio EI Ann Rheum Dis; 2004 Jun; 63(6):649-55. PubMed ID: 15140771 [TBL] [Abstract][Full Text] [Related]
20. Expression of several resistance mechanisms in untreated human kidney and lung carcinomas. Volm M; Mattern J; Efferth T; Pommerenke EW Anticancer Res; 1992; 12(4):1063-7. PubMed ID: 1354430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]